167 related articles for article (PubMed ID: 32900325)
1. The cost-effectiveness of adjunctive corticosteroids for patients with septic shock.
Thompson KJ; Taylor CB; Venkatesh B; Cohen J; Hammond NE; Jan S; Li Q; Myburgh J; Rajbhandari D; Saxena M; Kumar A; Finfer SR;
Crit Care Resusc; 2020 Sep; 22(3):191-199. PubMed ID: 32900325
[TBL] [Abstract][Full Text] [Related]
2. Long-term costs and cost-effectiveness of adjunctive corticosteroids for patients with septic shock in New Zealand.
Thompson KJ; Young PJ; Venkatesh B; Cohen J; Finfer SR; Grattan S; Hammond NE; Jan S; Li Q; Di Tanna GL; McArthur C; Myburgh J; Rajbhandari D; Taylor CB
Aust Crit Care; 2022 May; 35(3):241-250. PubMed ID: 34325975
[TBL] [Abstract][Full Text] [Related]
3. Cost Analysis of Adjunctive Hydrocortisone Therapy for Septic Shock: U.S. Payer Perspective.
Oh M; Patanwala AE; Alkhatib N; Almutairi A; Abraham I; Erstad B
Crit Care Med; 2020 Oct; 48(10):e906-e911. PubMed ID: 32701552
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.
Venkatesh B; Finfer S; Cohen J; Rajbhandari D; Arabi Y; Bellomo R; Billot L; Correa M; Glass P; Harward M; Joyce C; Li Q; McArthur C; Perner A; Rhodes A; Thompson K; Webb S; Myburgh J;
N Engl J Med; 2018 Mar; 378(9):797-808. PubMed ID: 29347874
[TBL] [Abstract][Full Text] [Related]
5. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.
Annane D; Sébille V; Charpentier C; Bollaert PE; François B; Korach JM; Capellier G; Cohen Y; Azoulay E; Troché G; Chaumet-Riffaud P; Bellissant E
JAMA; 2002 Aug; 288(7):862-71. PubMed ID: 12186604
[TBL] [Abstract][Full Text] [Related]
6. Hydrocortisone Compared with Placebo in Patients with Septic Shock Satisfying the Sepsis-3 Diagnostic Criteria and APROCCHSS Study Inclusion Criteria: A Post Hoc Analysis of the ADRENAL Trial.
Venkatesh B; Finfer S; Cohen J; Rajbhandari D; Arabi Y; Bellomo R; Billot L; Glass P; Joyce C; Li Q; McArthur C; Perner A; Rhodes A; Thompson K; Webb S; Myburgh J
Anesthesiology; 2019 Dec; 131(6):1292-1300. PubMed ID: 31651531
[TBL] [Abstract][Full Text] [Related]
7. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Fujii T; Luethi N; Young PJ; Frei DR; Eastwood GM; French CJ; Deane AM; Shehabi Y; Hajjar LA; Oliveira G; Udy AA; Orford N; Edney SJ; Hunt AL; Judd HL; Bitker L; Cioccari L; Naorungroj T; Yanase F; Bates S; McGain F; Hudson EP; Al-Bassam W; Dwivedi DB; Peppin C; McCracken P; Orosz J; Bailey M; Bellomo R;
JAMA; 2020 Feb; 323(5):423-431. PubMed ID: 31950979
[TBL] [Abstract][Full Text] [Related]
8. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial.
Gordon AC; Mason AJ; Perkins GD; Stotz M; Terblanche M; Ashby D; Brett SJ
Crit Care Med; 2014 Jun; 42(6):1325-33. PubMed ID: 24557425
[TBL] [Abstract][Full Text] [Related]
9. Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.
Keh D; Trips E; Marx G; Wirtz SP; Abduljawwad E; Bercker S; Bogatsch H; Briegel J; Engel C; Gerlach H; Goldmann A; Kuhn SO; Hüter L; Meier-Hellmann A; Nierhaus A; Kluge S; Lehmke J; Loeffler M; Oppert M; Resener K; Schädler D; Schuerholz T; Simon P; Weiler N; Weyland A; Reinhart K; Brunkhorst FM;
JAMA; 2016 Nov; 316(17):1775-1785. PubMed ID: 27695824
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.
; Annane D; Cariou A; Maxime V; Azoulay E; D'honneur G; Timsit JF; Cohen Y; Wolf M; Fartoukh M; Adrie C; Santré C; Bollaert PE; Mathonet A; Amathieu R; Tabah A; Clec'h C; Mayaux J; Lejeune J; Chevret S
JAMA; 2010 Jan; 303(4):341-8. PubMed ID: 20103758
[TBL] [Abstract][Full Text] [Related]
11. The ADRENAL study protocol: adjunctive corticosteroid treatment in critically ill patients with septic shock.
Venkatesh B; Myburgh J; Finfer S; Webb SA; Cohen J; Bellomo R; McArthur C; Joyce CJ; Rajbhandari D; Glass P; Harward M;
Crit Care Resusc; 2013 Jun; 15(2):83-8. PubMed ID: 23931038
[TBL] [Abstract][Full Text] [Related]
12. A Randomized Controlled Trial of Corticosteroids in Pediatric Septic Shock: A Pilot Feasibility Study.
Menon K; McNally D; O'Hearn K; Acharya A; Wong HR; Lawson M; Ramsay T; McIntyre L; Gilfoyle E; Tucci M; Wensley D; Gottesman R; Morrison G; Choong K;
Pediatr Crit Care Med; 2017 Jun; 18(6):505-512. PubMed ID: 28406862
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of early goal-directed therapy: an economic evaluation alongside the ARISE trial.
Higgins AM; Peake SL; Rinaldo Bellomo AO; Ao DJC; Delaney A; Howe BD; Nichol AD; Webb SA; Williams PJ; Harris AH;
Crit Care Resusc; 2021 Sep; 23(3):329-336. PubMed ID: 38046082
[No Abstract] [Full Text] [Related]
14. Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock.
Mouncey PR; Osborn TM; Power GS; Harrison DA; Sadique MZ; Grieve RD; Jahan R; Tan JC; Harvey SE; Bell D; Bion JF; Coats TJ; Singer M; Young JD; Rowan KM
Health Technol Assess; 2015 Nov; 19(97):i-xxv, 1-150. PubMed ID: 26597979
[TBL] [Abstract][Full Text] [Related]
15. Effect of Low-Dose Hydrocortisone Therapy in Adult Patients With Septic Shock: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials.
Lyu QQ; Chen QH; Zheng RQ; Yu JQ; Gu XH
J Intensive Care Med; 2020 Oct; 35(10):971-983. PubMed ID: 30270720
[TBL] [Abstract][Full Text] [Related]
16. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.
Annane D; Renault A; Brun-Buisson C; Megarbane B; Quenot JP; Siami S; Cariou A; Forceville X; Schwebel C; Martin C; Timsit JF; Misset B; Ali Benali M; Colin G; Souweine B; Asehnoune K; Mercier E; Chimot L; Charpentier C; François B; Boulain T; Petitpas F; Constantin JM; Dhonneur G; Baudin F; Combes A; Bohé J; Loriferne JF; Amathieu R; Cook F; Slama M; Leroy O; Capellier G; Dargent A; Hissem T; Maxime V; Bellissant E;
N Engl J Med; 2018 Mar; 378(9):809-818. PubMed ID: 29490185
[TBL] [Abstract][Full Text] [Related]
17. Hydrocortisone Therapy in Catecholamine-Resistant Pediatric Septic Shock: A Pragmatic Analysis of Clinician Practice and Association With Outcomes.
Nichols B; Kubis S; Hewlett J; Yehya N; Srinivasan V
Pediatr Crit Care Med; 2017 Sep; 18(9):e406-e414. PubMed ID: 28658197
[TBL] [Abstract][Full Text] [Related]
18. Concomitant arginine-vasopressin and hydrocortisone therapy in severe septic shock: association with mortality.
Torgersen C; Luckner G; Schröder DC; Schmittinger CA; Rex C; Ulmer H; Dünser MW
Intensive Care Med; 2011 Sep; 37(9):1432-7. PubMed ID: 21779849
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
[TBL] [Abstract][Full Text] [Related]
20. Hydrocortisone therapy for patients with septic shock.
Sprung CL; Annane D; Keh D; Moreno R; Singer M; Freivogel K; Weiss YG; Benbenishty J; Kalenka A; Forst H; Laterre PF; Reinhart K; Cuthbertson BH; Payen D; Briegel J;
N Engl J Med; 2008 Jan; 358(2):111-24. PubMed ID: 18184957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
